World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
45
Citations
8286
World Ranking
4695
National Ranking
2120

Sheila M. Keating publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sheila M. Keating sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 160 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sheila M. Keating D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sheila M. Keating sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 45 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sheila M. Keating is affiliated with the University of California, San Francisco in the United States. Their research primarily focuses on fields related to medicine, with a particular emphasis on infectious diseases, virology, emergency medicine, epidemiology, and immunology.

Their work covers key topics including HIV research and treatment, HIV-related health complications and treatments, HIV/AIDS research and interventions, SARS-CoV-2 and COVID-19 research, monoclonal and polyclonal antibodies research, hepatitis C virus research, and tryptophan and brain disorders.

Frequent publication venues for Sheila M. Keating include:

  • PLoS ONE
  • The Journal of Infectious Diseases
  • Anesthesiology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Zenodo (CERN European Organization for Nuclear Research)

They have collaborated extensively with several researchers, including:

  • Philip J. Norris
  • Adam S. Adler
  • Michael P. Busch
  • Leah H. Rubin
  • Kathleen M. Weber

Notable recent publications by Sheila M. Keating include:

  • Generation of recombinant hyperimmune globulins from diverse B-cell repertoires, 2021, Nature Biotechnology
  • Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression, 2021, PLoS ONE
  • Remitted depression and cognition in HIV: The role of cortisol and inflammation, 2020, Psychoneuroendocrinology
  • Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size, 2020, The Journal of Infectious Diseases
  • Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program, 2020, Transfusion

Best Publications

  • Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

    Helen McShane;Ansar A Pathan;Clare R Sander;Sheila M Keating

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation: Report of 2 Cases

    Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano

  • Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient

    Steven A. Yukl;Eli Boritz;Michael Busch;Christopher Bentsen

  • Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

    Timothy J. Henrich;Timothy J. Henrich;Zixin Hu;Zixin Hu;Jonathan Z. Li;Jonathan Z. Li;Gaia Sciaranghella

  • Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

    Daniel P. Webster;Susanna Dunachie;Jenni M. Vuola;Tamara Berthoud

  • A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

    S. J. Dunachie;M. Walther;J. E. Epstein;S. Keating

  • Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: results of the REDS-III RBC-Omics study.

    Tamir Kanias;Marion C. Lanteri;Marion C. Lanteri;Grier P. Page;Yuelong Guo

  • A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults.

    Vasee S Moorthy;Egeruan B Imoukhuede;Paul Milligan;Kalifa Bojang

  • Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

    Norman L. Letvin;Srinivas S. Rao;David C. Montefiori;Michael S. Seaman

  • Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers

    Jenni M. Vuola;Sheila Keating;Daniel P. Webster;Tamara Berthoud

  • A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya

    Philip Bejon;Jedidah Mwacharo;Oscar Kai;Tabitha Mwangi;Tabitha Mwangi

  • Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria

    Sheila M. Keating;Philip Bejon;Tamara Berthoud;Jenni M. Vuola

  • The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.

    Sheila M. Keating;Sheila M. Keating;Elizabeth T. Golub;Marek Nowicki;Mary Young

  • Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository

    Reshma Kassanjee;Reshma Kassanjee;Christopher D. Pilcher;Sheila M. Keating;Shelley N. Facente

  • Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.

    Sarah C. Gilbert;Vasee S. Moorthy;Laura Andrews;Ansar A. Pathan

  • Phase 1 Evaluation of 3 Highly Immunogenic Prime-Boost Regimens, Including a 12-Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men

    Vasee S. Moorthy;Egeruan B. Imoukhuede;Sheila Keating;Margaret Pinder

  • Alloreactive fetal T cells promote uterine contractility in preterm labor via IFN-γ and TNF-α.

    Michela Frascoli;Lacy Coniglio;Russell Witt;Cerine Jeanty

  • Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys

    Jinyan Liu;Brandon F. Keele;Hui Li;Sheila Keating

  • A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.

    Susanna J. Dunachie;Michael Walther;Jenni M. Vuola;Daniel P. Webster

  • The Induction and Persistence of T Cell IFN-γ Responses after Vaccination or Natural Exposure Is Suppressed by Plasmodium falciparum

    Philip Bejon;Jedidah Mwacharo;Oscar Kai;Stephen Todryk

  • Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation

    Timothy J. Henrich;Emily Hanhauser;Francisco M. Marty;Michael N. Sirignano

Frequent Co-Authors

Philip J. Norris
Philip J. Norris University of California, San Francisco
Michael P. Busch
Michael P. Busch University of California, San Francisco
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Christopher D. Pilcher
Christopher D. Pilcher University of California, San Francisco
Lishomwa C. Ndhlovu
Lishomwa C. Ndhlovu Cornell University
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Philip Bejon
Philip Bejon University of Oxford
Stephen Todryk
Stephen Todryk Northumbria University
Susanna Dunachie
Susanna Dunachie University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. Many students explore related online degrees to complement their knowledge or shift into specialized roles. For those interested in nursing, accelerated paths like the nurse practitioner accelerated program offer a fast track to advanced clinical practice. These programs are designed for professionals seeking to expand their scope and impact patient care directly.

For individuals without a nursing background, there are options such as the best online bsn programs for non nurses, allowing a smoother transition into the nursing field. These programs are tailored to build foundational nursing knowledge efficiently, making them ideal for career changers.

If accessibility is a priority, finding an easiest absn to get into can be a strategic step. These programs balance quality education with more flexible admissions requirements, enabling more students to pursue nursing degrees quickly.

Additionally, entry-level options like lpn schools easy to get into provide pathways for those starting their healthcare journey. Licensed Practical Nurse programs offer hands-on experience and can be stepping stones toward advanced qualifications in immunology-related healthcare roles.

Best Scientists Citing Sheila M. Keating

Trending Scientists

Recently Published Articles